Clinical Report: A preliminary randomized controlled study of a comprehensive intervention aimed at enhancing sexual function in women who have survived breast cancer
Overview
This pilot randomized controlled trial assessed the feasibility of a combined hypnotic relaxation intervention and vaginal moisturizer for improving sexual function and body image in female breast cancer survivors. Results indicated improvements in sexual desire, body image, and genitourinary syndrome of menopause (GSM) symptoms, though specific significance levels were not detailed.
Background
Sexual health issues are prevalent among breast cancer survivors, affecting 30%–80% of this population, according to various studies. These challenges often include symptoms of genitourinary syndrome of menopause (GSM) and psychological factors such as negative body image. Addressing these concerns is crucial for improving overall quality of life in this demographic.
Data Highlights
Outcome
Effect Size (d)
FSFI lubrication
1.50 (0.97, 2.02)
Pain
0.81 (0.39, 1.22)
SexFS V2 interest
0.37
Body image
0.42
Key Findings
Thirty participants were randomized to either the hypnotic relaxation intervention (HRI) or vaginal moisturizer alone (VMO).
Study completion was achieved by all participants, with adherence rates of 92% for HRI and 90% for VMO.
Improvements in sexual desire, body image, and GSM-related outcomes were observed in both groups, with change-score effects favoring HRI over VMO for sexual interest and body image.
FSFI lubrication showed a large effect size, indicating improvement.
Clinical Implications
The findings indicate that a combined approach of hypnotic relaxation and vaginal moisturizer may address sexual health issues in breast cancer survivors.
Conclusion
This study demonstrates the feasibility of a combined intervention for enhancing sexual function and body image among breast cancer survivors, warranting further investigation in larger trials.
